• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与视网膜母细胞瘤晚期复发和全身转移相关的视网膜色素上皮腺癌

Adenocarcinoma of the Retinal Pigment Epithelium Arising in Conjunction with Late Recurrence and Systemic Metastasis of Retinoblastoma.

作者信息

Roelofs Kelsey, Kherani Femida, Russell Laurie, Heathcote J Godfrey, Weis Ezekiel

机构信息

Department of Ophthalmology and Visual Sciences.

Department of Surgery, University of Calgary, Calgary, AB.

出版信息

Ocul Oncol Pathol. 2017 Nov;3(4):296-300. doi: 10.1159/000468523. Epub 2017 Apr 14.

DOI:10.1159/000468523
PMID:29344484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5757590/
Abstract

In 1974, an 8-month-old male was diagnosed with bilateral retinoblastoma. His left eye was enucleated, while the right eye was salvaged with a combination of external beam radiotherapy (4,000 cGy total, divided in 20 fractions) and retinal laser treatment. Thirty-nine years later, he developed intraocular recurrence of retinoblastoma with extrascleral spread. Histopathological examination also identified a second distinct malignancy, retinal pigment epithelium adenocarcinoma, arising in continuity with the retinoblastoma. Further investigation revealed foci of metastatic retinoblastoma in his parotid gland. He was subsequently treated with a combination of orbital exenteration, extensive neck dissection, and resection of metastatic foci, followed by a high-dose ablative chemotherapeutic regimen consisting of cisplatin, vincristine, and cyclophosphamide. Although very rare, late recurrence of retinoblastoma with systemic metastasis is possible, and continued clinical observation and appropriate long-term follow-up should be considered. Additionally, it is important to consider a second primary intraocular tumor in the differential diagnosis, especially in a patient with heritable retinoblastoma who has undergone radiation therapy.

摘要

1974年,一名8个月大的男性被诊断为双侧视网膜母细胞瘤。他的左眼被摘除,而右眼通过外照射放疗(总量4000 cGy,分20次进行)和视网膜激光治疗得以保留。39年后,他发生了视网膜母细胞瘤眼内复发并伴有巩膜外扩散。组织病理学检查还发现了第二种不同的恶性肿瘤,即视网膜色素上皮腺癌,与视网膜母细胞瘤连续发生。进一步检查发现他的腮腺有转移性视网膜母细胞瘤病灶。随后,他接受了眶内容摘除术、广泛的颈部清扫术和转移灶切除术,接着进行了由顺铂、长春新碱和环磷酰胺组成的高剂量消融化疗方案。尽管非常罕见,但视网膜母细胞瘤晚期复发并伴有全身转移是有可能的,应考虑持续的临床观察和适当的长期随访。此外,在鉴别诊断中考虑第二种原发性眼内肿瘤很重要,特别是在接受过放射治疗的遗传性视网膜母细胞瘤患者中。

相似文献

1
Adenocarcinoma of the Retinal Pigment Epithelium Arising in Conjunction with Late Recurrence and Systemic Metastasis of Retinoblastoma.与视网膜母细胞瘤晚期复发和全身转移相关的视网膜色素上皮腺癌
Ocul Oncol Pathol. 2017 Nov;3(4):296-300. doi: 10.1159/000468523. Epub 2017 Apr 14.
2
Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.视网膜母细胞瘤中化学减灭术失败的原因及导致最终采用外照射放疗和眼球摘除术治疗的相关因素分析。
Ophthalmology. 2004 Oct;111(10):1917-24. doi: 10.1016/j.ophtha.2004.04.016.
3
Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.E 组视网膜母细胞瘤的化学减容:76 只眼单纯化学减容与化学减容加低剂量外照射放疗的比较
Ophthalmology. 2009 Mar;116(3):544-551.e1. doi: 10.1016/j.ophtha.2008.10.014. Epub 2009 Jan 20.
4
Retinoblastoma CSF metastasis cured by multimodality chemotherapy without radiation.多模态化疗治愈视网膜母细胞瘤脑脊液转移,无需放疗。
Ophthalmic Genet. 2009 Sep;30(3):121-6. doi: 10.1080/13816810902988780.
5
Atypical Retinal Pigment Epithelial Hyperplasia and Glial Proliferation Masquerading as Progressive Recurrent Retinoblastoma: A Case Report Review and Clinicopathologic Correlation.非典型视网膜色素上皮增生和胶质细胞增生伪装成进展性复发性视网膜母细胞瘤:病例报告回顾及临床病理相关性分析
Ocul Oncol Pathol. 2018 Sep;4(2):116-121. doi: 10.1159/000479741. Epub 2017 Sep 16.
6
Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.全身化学减瘤治疗与初次眼球摘除术治疗晚期视网膜母细胞瘤眼的转移和眼眶复发风险。
Pediatr Blood Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26270. Epub 2016 Nov 5.
7
Management of massive orbital involvement of intraocular retinoblastoma.眼内视网膜母细胞瘤大量眼眶受累的处理
Ophthalmology. 1998 Feb;105(2):322-6. doi: 10.1016/s0161-6420(98)93367-x.
8
Preliminary results of primary chemotherapy in retinoblastoma.视网膜母细胞瘤原发性化疗的初步结果。
Klin Padiatr. 1997 Jul-Aug;209(4):216-21. doi: 10.1055/s-2008-1043953.
9
Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.视网膜母细胞瘤化疗减积术后视网膜肿瘤、玻璃体种植和视网膜下种植复发的预测因素。
Arch Ophthalmol. 2002 Apr;120(4):460-4.
10
Orbital Recurrence following Aggressive Laser Treatment for Recurrent Retinoblastoma.复发性视网膜母细胞瘤积极激光治疗后的眼眶复发
Ocul Oncol Pathol. 2015 Dec;2(2):76-9. doi: 10.1159/000439055. Epub 2015 Sep 18.

引用本文的文献

1
Retinal Pigment Epithelium Adenoma and Adenocarcinoma: A Review.视网膜色素上皮腺瘤和腺癌:综述
Ocul Oncol Pathol. 2021 Mar;7(2):121-132. doi: 10.1159/000509484. Epub 2020 Dec 22.

本文引用的文献

1
Risk definition and management strategies in retinoblastoma: current perspectives.视网膜母细胞瘤的风险定义与管理策略:当前观点
Clin Ophthalmol. 2015 Jun 8;9:985-94. doi: 10.2147/OPTH.S59828. eCollection 2015.
2
Very late relapse of bilateral retinoblastoma.双侧视网膜母细胞瘤的极晚期复发
J Pediatr Hematol Oncol. 2015 May;37(4):e264-7. doi: 10.1097/MPH.0000000000000310.
3
High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.基于国际视网膜母细胞瘤分类的高危视网膜母细胞瘤:519 例眼球摘除眼分析。
Ophthalmology. 2013 May;120(5):997-1003. doi: 10.1016/j.ophtha.2012.10.044. Epub 2013 Feb 8.
4
Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.视网膜母细胞瘤的治疗:眼球摘除术、静脉化疗和动脉内化疗的进展。
Curr Opin Ophthalmol. 2010 May;21(3):203-12. doi: 10.1097/ICU.0b013e328338676a.
5
Aggressive metastasising adenocarcinoma of the retinal pigment epithelium with trisomy 21.伴有21三体综合征的侵袭性转移性视网膜色素上皮腺癌
Br J Ophthalmol. 2008 Mar;92(3):389-91. doi: 10.1136/bjo.2007.127886.
6
Diagnostic surprise in an evisceration specimen.一例剖腹探查标本中的诊断意外情况。
Orbit. 2007 Jun;26(2):129-31. doi: 10.1080/01676830600974902.
7
Basic understanding of current classification and management of retinoblastoma.对视网膜母细胞瘤当前分类和管理的基本理解。
Curr Opin Ophthalmol. 2006 Jun;17(3):228-34. doi: 10.1097/01.icu.0000193079.55240.18.
8
Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up.视网膜母细胞瘤长期幸存者放疗后新发癌症的风险:延长随访
J Clin Oncol. 2005 Apr 1;23(10):2272-9. doi: 10.1200/JCO.2005.05.054.
9
Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.视网膜母细胞瘤的化学减灭法。457例肿瘤的肿瘤控制及复发风险分析。
Am J Ophthalmol. 2004 Sep;138(3):329-37. doi: 10.1016/j.ajo.2004.04.032.
10
Recurrence of retinoblastoma 12 years after brachytherapy.近距离放射治疗12年后视网膜母细胞瘤复发。
Am J Ophthalmol. 2002 Nov;134(5):773-5. doi: 10.1016/s0002-9394(02)01693-8.